Identification and Treatment of Renal Stenosis in Transplanted Kidneys
Condition(s) studied
Study summary
Renal artery stenosis is a complication that may follow kidney transplantation1-5. Renal artery stenosis greater than 50% of the lumen of the artery, associated with clinical symptoms or laboratory worsening of renal function, may lead to transplant failure, however, the indications for treatment and the modalities of treatment remain, to date, a debated topic in the literature. The guidelines of the European Society of Urology recommend endovascular treatment as the first-line treatment by means of angioplasty and/or stent placement6. A recent review of the literature7 examined the results of 56 studies: the results fully support endovascular treatment of the disease which appears to be effective and with a low rate of complications.
Eligibility
Primary outcome measure(s)
- Reduction of stenosis — From the first patient enrolled up to the 30th patient, an average of 3 years
Efficacy is assessed by a reduction in stenosis of at least 50% based on the TC image - Renal function improvement — From the first patient enrolled, up to the 30th patient. An average of 3 years
It is assessed through the improvement in eGFR and Creatinine values, compared to baseline.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| IRCCS AOU di Bologna Policlinico di Sant'Orsola | Bologna | Italy | Recruiting |
More IRCCS Azienda Ospedaliero-Universitaria di Bologna trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06822205 on ClinicalTrials.gov ↗ ← All trials in Italy